相关实验视频
Updated: Jan 12, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
关于在怀孕期间在1型糖尿病中使用自动化胰岛素输送的审查
Elaine Young1, Andrew R Goyette2, Jeremy F Alkire3
1Children's Hospital Los Angeles, Los Angeles, California.
概括
自动化胰岛素输送系统 (AID) 显示出改善孕期糖尿病孕妇血糖控制的潜力,但没有一个系统能够始终满足所有孕期特定目标. 需要对怀孕期间的2型糖尿病进行进一步研究.
科学领域:
- 内分泌学 在内分泌学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 医疗技术 医疗技术 医学技术
背景情况:
- 在孕期糖尿病中怀孕带来了独特的血糖管理挑战.
- 自动胰岛素输送系统 (AID) 提供先进的葡萄糖控制,但在怀孕期间需要特别考虑.
研究的目的:
- 对怀孕期间糖尿病的孕妇使用AID的临床证据进行审查.
- 概述美国可用的AID系统,并为妊娠特定使用提供临床指导.
主要方法:
- 随机对照试验 (RCT) 在孕期糖尿病中对AID进行系统审查.
- 6个AID系统的特征和定制的比较,用于怀孕的血糖目标.
主要成果:
- 在1型糖尿病的6项RCT中,AID血糖结局与标准治疗相比显示出混合的结果.
- 孕产妇和新生儿的结局通常相似;一些研究指出,随着AID,孕期体重增加减少.
- CamAPS FX已获得FDA对T1D怀孕的批准,但未在美国提供;没有AID系统始终满足所有怀孕血糖指标.
结论:
- 尽管没有完美的系统,但有策略可以优化AID用于怀孕的血糖目标.
- 更多的研究对AID对孕产妇/胎儿和患者报告的结果的影响至关重要,特别是在2型糖尿病.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Insulin: Dosing Regimen and Adverse Effects
670
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
670
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Insulin Formulations: Types and Delivery
638
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
638
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Management and Pharmacotherapy
856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856

